Work

Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies

Year: 2022

Type: article

Abstract: There has been a substantial growth in private clinics and registered clinical trials employing serotonergic psychedelics for various psychiatric illnesses, including substance use disorder[1][1],[2][2] and major depressive disorder.[3][3]–[6][4] Classical psychedelics include lysergic acid

Source: Journal of Psychiatry and Neuroscience

DOI: 10.1503/jpn.220090

Authors: Stephanie L. Borgland, Drew M. Neyens

Institutions: University of Calgary, Hotchkiss Brain Institute

Language: English

Topic: Psychedelics and Drug Studies

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Canadian Institutes of Health Research